In this episode, Hall welcomes Dr. Stuart Titus, Chief Executive Officer and President at Medical Marijuana, Inc.

Headquartered in Poway, California, Medical Marijuana, Inc. is a cannabis product research and development company. The Company offers various CBD oils and related products such as CBD tinctures, concentrates, beauty products and pet supplements. Medical Marijuana distributes its products to worldwide customers.

Stuart, a 10+ year pioneer of the cannabis industry, is the CEO of the first-ever publicly traded cannabis company in the US, Medical Marijuana, Inc. He has been involved in all aspects of the medical marijuana and industrial hemp industries overseeing a robust portfolio of subsidiaries and investments. Through his leadership, Medical Marijuana, Inc. became the first company to deliver cannabis brands across U.S. state lines, and the first to hold import permits for hemp-derived cannabidiol (CBD) in dozens of countries such as Mexico, Brazil, Paraguay, Argentina and many European nations.  

He is also a veteran of the financial services and medical healthcare industries with over thirty years of combined experience in each discipline. In the investment banking industry, Stuart worked with well-regarded firms including A.G. Becker, Prudential-Bache Securities, and Credit Suisse-First Boston.

Stuart shares with Hall how he sees the industry evolving and some of the challenges startups face.

You can visit Medical Marijuana, Inc. at www.mjnagroup.com, via LinkedIn at www.linkedin.com/company/medical-marijuana-inc-/, and via Twitter at
www.twitter.com/mjna_inc.   

Stuart can be contacted via email at Stuart@mjnagroup.com.

For a full transcript, click here.

Music courtesy of Bensound.

Copyright (c) 2024, Hall Martin and investorconnect.org. All rights reserved.

Disclaimer:
Hall T Martin is the director of Investor Connect, which is a 501(c)(3) nonprofit dedicated to the education of investors for early-stage funding. All opinions expressed by Hall and podcast guests are solely their own opinions and do not reflect the opinion of Investor Connect. This podcast is for informational purposes only and should not be relied upon for the basis of investment decisions.